InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Evolus, Inc.

EOLS Clue Score45
United States Fiscal year ends December CIK 0001570562 Results filed 4 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

26
Insider
Date
Role
Action
Shares
Price
Amount
David Moatazedi
20 Mar 2026
See Remarks
Sold on a plan
13,669
$4.75
$64.93K
Rui Avelar
17 Mar 2026
See Remarks
Sold on a plan
29,996
$4.89
$146.63K
David Moatazedi
17 Mar 2026
See Remarks
Sold on a plan
116,720
$4.89
$570.56K
Rui Avelar
22 Dec 2025
See Remarks
Sold on a plan
2,261
$7.15
$16.17K
David Moatazedi
22 Dec 2025
See Remarks
Sold on a plan
10,539
$7.15
$75.36K
Tomoko Yamagishi-Dressler
22 Aug 2025
Chief Marketing Officer
Sold on a plan
5,722
$7.51
$42.97K
Sandra Beaver
13 May 2025
Chief Financial Officer
Sold on a plan
6,494
$10.02
$65.07K
David Moatazedi
12 May 2025
See Remarks
Sold on a plan
15,787
$9.87
$155.76K
Rui Avelar
12 May 2025
See Remarks
Sold on a plan
3,385
$9.87
$33.40K
David Moatazedi
27 Mar 2025
See Remarks
Sold on a plan
6,251
$12.40
$77.51K
David Moatazedi
18 Mar 2025
See Remarks
Sold on a plan
103,376
$13.26
$1.37M
Tomoko Yamagishi-Dressler
18 Mar 2025
Chief Marketing Officer
Sold on a plan
4,536
$13.26
$60.12K
Sandra Beaver
18 Mar 2025
Chief Financial Officer
Sold on a plan
8,996
$13.26
$119.24K
Rui Avelar
18 Mar 2025
See Remarks
Sold on a plan
27,904
$13.26
$369.87K
David Moatazedi
23 Dec 2024
See Remarks
Sold on a plan
10,502
$10.85
$113.97K
Sandra Beaver
23 Dec 2024
Chief Financial Officer
Sold on a plan
1,586
$10.85
$17.21K
Rui Avelar
23 Dec 2024
See Remarks
Sold on a plan
2,252
$10.85
$24.44K
Sandra Beaver
22 Feb 2024
Chief Financial Officer
Sold on a plan
1,821
$13.08
$23.82K
Rui Avelar
22 Feb 2024
See Remarks
Sold on a plan
1,821
$13.08
$23.82K
David Moatazedi
22 Feb 2024
See Remarks
Sold on a plan
7,706
$13.08
$100.80K
Karah Herdman Parschauer
30 Jan 2024
Director
Sold on a plan
11,931
$13.14
$156.73K
Sandra Beaver
6 Sep 2023
Chief Financial Officer
Sold on a plan
3,178
$9.70
$30.83K
David Moatazedi
16 Aug 2023
See Remarks
Sold on a plan
14,778
$10.27
$151.77K
Sandra Beaver
16 Aug 2023
Chief Financial Officer
Sold on a plan
2,211
$10.27
$22.71K
Rui Avelar
16 Aug 2023
See Remarks
Sold on a plan
2,211
$10.27
$22.71K
David Moatazedi
27 Mar 2023
See Remarks
Sold on a plan
6,110
$8.47
$51.75K
Show all 142 transactions →

What was left out

Form 4 filings counted 224
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 26
Sales straight out of an exercise 2
Sales at will 69
Transactions with no price 0
Shares from compensation/vesting 15,064,534
Sales filed before the plan box existed 47
History held since 13 Feb 2018